Pharma Pulse 4/4/24: Baltimore Bridge Collapse Upends US Supply Chains, Can Employees Realistically Expect Any Good Jobs for 2024? & more
The latest news for pharma industry insiders.
In the Wake of the Great Resignation, Can Employees Realistically Expect Any Good Jobs for 2024?
A Q&A with Dr. Zeynep Ton, professor at the MIT Sloan School of Management.
CMS Finalizes 2025 Rates for Medicare Advantage and Part D Plans
Market shares have fallen for CVS, UnitedHealth Group and more following the announcement.
How the Baltimore Bridge Collapse Is Upending U.S. Supply Chains
The Dali containership stuck under Baltimore’s collapsed Francis Scott Key Bridge may remain in place for weeks, blocking shipping at one of the U.S.'s busiest ports. Here’s what that means for major industry supply chains.
Johnson & Johnson Expands Commitment to Advance Health Equity
Johnson & Johnson supports more than 100 community-led organizations in marginalized communities to provide resources and tools to advance accessible, quality health care in the US
It has been demonstrated that health outcomes improve when skills and tools improve resilience, which in turn improves adherence to any intervention
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
